NCT06939907

Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract

Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract: A Prospective, Multi-Center, Single-Arm, Open-Label, Pilot Clinical Trial

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Next Biomedical Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract

Conditions

• Lower Gastrointestinal Bleeding
• Diverticular Bleeding

Interventions

Type	Name	Description
DEVICE	Nexpowder™	Nexpowder™ hemostatic powder

Timeline

• Start date: 2025-06-01
• Primary completion: 2027-06-01
• Completion: 2027-07-01
• First posted: 2025-04-23
• Last updated: 2025-04-25

Locations

6 sites across 1 country: South Korea